Page last updated: 2024-08-25

stearoyl alpha-lysolecithin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

stearoyl alpha-lysolecithin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, SJ; Jung, DB; Jung, JH; Jung, SK; Kim, JH; Kim, SH; Lee, D; Lee, HJ; Sohn, EJ; Yun, M1

Other Studies

1 other study(ies) available for stearoyl alpha-lysolecithin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Inactivation of HDAC3 and STAT3 is critically involved in 1-stearoyl-sn-glycero-3-phosphocholine-induced apoptosis in chronic myelogenous leukemia K562 cells.
    Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3

    Topics: Acetylation; Apoptosis; bcl-X Protein; Cell Line, Tumor; Histone Deacetylases; Histones; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophosphatidylcholines; Promoter Regions, Genetic; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor

2013